BioSpace News Archive

Tiziana Life Sciences plc today announces that it has formally commenced its strategic plan to change its corporate structure by establishing Tiziana Life Sciences Ltd (“ New Tiziana ”), a Bermuda-incorporated company, as the ultimate parent company of the of the Tiziana Group.

Vizient, Inc. announced today a new agreement with The University of Texas System that significantly expands the services and solutions used to deliver cost effective care to patients.

Rafael Holdings, Inc. (NYSE: RFL) today announced that it has entered into definitive agreements to sell securities in a private placement that is expected to result in gross proceeds to the company of $104.2 million , before deducting placement agent and other offering expenses.

Agile Therapeutics, Inc. today announced a partnership with Pandia Health, an online telehealth service, which will establish the first telehealth relationship for Agile and offer an additional point of access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system in a fast-growing channel.

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in collaboration with the Infectious Disease Research Institute (IDRI).

Silicon Labs today announced the addition of “IoT is Changing Healthcare – Now Adoption is Critical,” a panel of IoT and healthcare experts to Works With on September 15, 2021.

Savara Inc. today announced the grant of inducement awards to two new employees.

Vivera Pharmaceuticals, Inc. (Vivera) today announced that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,083,850 for ZICOH®, the Company’s wireless, electronic, dose-controlled medication delivery device.

Adial Pharmaceuticals, Inc. will host a conference call at 11:00 A.M. Eastern Time today, August 20, 2021 to provide a clinical update and discuss the latest business developments.

The cardiac rehabilitation market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.2% during 2021–2028.